genomes encode 121 and 79 V2R genes, respectively) (Young and Trask, 2007) . Conversely, functional V2Rs are absent in other mammalian species, such as dogs or apes, in which only a single Mup gene has been found. An apparent correlation thus exists between the expansion of the V2R gene repertoires and the Mup gene repertoires in mice and rats. The strength of this correlation will soon be put to the test by comparative genomics of different rodent species. In parallel, the functional relevance could be evaluated by the potentially altered response to kairomones of mice lacking β2-microglobulin, a critical player in targeting V2Rs to the plasma membrane (Loconto et al., 2003) . Thus, the identification of Mups as triggers of distinct and very robust hard-wired behavioral responses in mice is likely to lead to new insights into the coding strategies underlying rodent innate behaviors.
To survive a viral infection, the immune system triggers an arsenal of protective defense measures. One of the most potent of these is the induction of type I interferons. These cytokines orchestrate both rapid and long-term responses that inhibit viral replication and assembly. Immune sensors inside cells detect viral genomes or the replicative activities of viruses to initiate this antiviral state (Takeuchi and Akira, 2009 ). In the case of RNA viruses, the RNA helicases retinoic acid-inducible gene I (RIG-I) and melanoma differentiationassociated gene 5 (MDA-5) discriminate between different classes of RNA viruses in the cytosol (Figure 1 ). RIG-I senses the 5′ triphosphate moiety of viral genomes or short blunt-ended double-stranded RNA molecules, while MDA-5 recognizes long double-stranded RNA molecules (a typical intermediate during the replication of certain viruses). Upon binding to these viral components, both RIG-I and MDA-5 then interact with MAVS (also called IPS-1, Cardif, or VISA), which triggers an antiviral signaling cascade. This leads to the activation of NF-κB and interferon regulatory factor 3 (IRF3), which subsequently turn on the expression of genes encoding inflammatory cytokines and type I interferons (Figure 1 ).
MAVS contains a C-terminal transmembrane domain, which targets the protein to the outer membrane of mitochondria. This localization of MAVS is essential for signaling because cleavage, deletion, or mutation of the mitochondrialtargeting sequence of MAVS disrupts the antiviral response (Li et al., 2005; Seth et al., 2005; Meylan et al., 2005) . In this issue of Cell, Dixit et al. (2010) now show that MAVS is also found on other membrane-bound organelles in the cytosol called peroxisomes. Peroxisomal MAVS establishes an immediate albeit transient antiviral response, which halts or delays viral replication until the more robust and sustained antiviral response driven by the mitochondrial MAVS pathway comes into play.
Peroxisomes, best known for their role in the oxidation of lipids, contain a large number of oxidative enzymes within their lumen. Peroxisomes originate from the endoplasmic reticulum (ER), but they freely exchange proteins with mitochondria (Camões et al., 2009 To defend cells against viruses, the MAVS (mitochondrial antiviral signaling) adaptor protein initiates an antiviral signaling cascade from mitochondrial membranes. In this issue, Dixit et al. (2010) show that MAVS also localizes to the membranes of peroxisomes, where it rapidly induces expression of a subset of antiviral genes that curb viral replication until mitochondrial MAVS can induce a sustained antiviral response.
Cell 141, May 14, 2010 ©2010 Elsevier Inc. 571 associated with the ER, the plasma membrane, or the endocytic system that imports proteins from the plasma membrane to the cell interior . However, the C-terminal tail that anchors MAVS to mitochondrial membranes is similar to targeting motifs in mitochondrial fission 1 (Fis-1) protein and mitochondrial fission factor (Mff) protein, which both localize not only to mitochondrial membranes but also to those of peroxisomes (Gandre-Babbe and van der Bliek, 2008; Koch et al., 2005) . This sequence similarity and the considerable membrane crosstalk between peroxisomes and mitochondria (Camões et al., 2009 ) prompted Dixit et al. (2010 to check whether MAVS also localizes to peroxisomes. Indeed, they found that MAVS constitutively associates with both mitochondria and peroxisomes in mouse and human cells. They initially hypothesized that the role of peroxisomes was simply to route MAVS correctly to mitochondria. However, the delivery of MAVS to the mitochondria was normal in cells that lacked peroxisomes. Thus, to determine the purpose of MAVS in peroxisomes, the authors generated cell lines in which the C-terminal localization motif of MAVS was either deleted or replaced with another motif known to target proteins to a single compartment of the cell. This created three different versions of MAVS that each localized exclusively to the cytosol, mitochondrial membranes, or peroxisomal membranes. Except for the cytosolic form, each MAVS variant induced the production of a wellcharacterized antiviral protein, viperin, in response to infection with reovirus, which signals via RIG-I and MDA-5 (Loo et al., 2008) . Interestingly, although MAVS on peroxisomes or wild-type MAVS induced production of viperin within 4 hr of reovirus infection, expression of MAVS exclusively on mitochondria significantly delayed induction of this interferon-stimulated gene product. Further analysis of other interferon-stimulated genes indicated that the signaling pathways triggered by peroxisomal MAVS contribute to a more rapid (albeit transient) induction of these antiviral factors after reovirus infection. Mitochondrial MAVS also induced the expression of interferon-stimulated genes, but the kinetics was significantly slower. The RNA helicases retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA-5) are part of the immune system's antiviral defense system. These proteins detect viral RNA and then interact with MAVS, an adaptor molecule on mitochondrial membranes. Detection of viral nucleic acids by these helicases and signaling via mitochondrial MAVS induces the expression of type I interferons (IFNs) and eventually leads to virus control. Dixit et al. (2010) now show that MAVS is also present on metabolic organelles called peroxisomes. Peroxisomal MAVS is essential for the rapid expression of antiviral genes called interferon-stimulated genes (ISGs). This gene expression, which is independent of type I IFN production, results in an early but transient antiviral response. However, type I IFN induction by the mitochondrial MAVS pathway is necessary for the eventual clearance of the virus. The different outcomes observed for the two MAVS pathways may relate to the fact that peroxisomal MAVS activates interferon regulatory factor 1 (IRF1) in addition to IRF3. It is possible that an IRF1-IRF3 heterodimer induces expression of ISGs but not type I IFN genes. These studies reveal that MAVS signaling from both peroxisomes and mitochondria is necessary for maximal containment of virus replication.
The authors obtained similar results when they infected cells with influenza virus, which activates MAVS exclusively through interactions with RIG-I.
In contrast to cells with mitochondrial MAVS, those with peroxisomal MAVS did not produce type I interferons, indicating that these potent antiviral cytokines are not a prerequisite for the induction of viperin by MAVS signaling from peroxisomes. Strikingly, Dixit and colleagues found that cells with peroxisomal MAVS were as efficient at controlling the replication of vesicular stomatitis virus (VSV) as cells with wild-type MAVS. VSV fails to induce type I interferons, but it still induces interferon-stimulated genes, like viperin (Ferran and Lucas-Lenard, 1997) . Thus, these important findings indicate that peroxisomal MAVS plays a bona fide role in controlling viral infection independently of type I interferons and most probably does so through the early induction of interferon-stimulated genes, such as viperin and ISG15 (a ubiquitin-like protein that inhibits viral production) (Figure 1) .
This study highlights a number of important new themes. First, it reveals that peroxisomes are not simply metabolic organelles but rather serve as signaling platforms to orchestrate an immediate immune response against virus infection. This early antiviral state curbs the infection until enough interferon is produced to induce the expression of a complete panel of interferon-stimulated genes and to halt viral replication permanently. Second, the study demonstrates that early expression of a subset of antiviral genes can control viral infection independently of type I interferon production. An extremely interesting conundrum raised by these studies is the apparent failure of peroxisomal MAVS signaling to stimulate the expression of type I interferon genes even though this MAVS still activates IRF3 (Figure 1) . The peroxisomal pathway also uses IRF1; thus, perhaps a heterodimeric complex of IRF1 and IRF3 favors transcription of interferon-stimulated genes but not that of type I interferon genes.
This exciting study also indicates how distinct temporal and compartmentalized antiviral responses from peroxisomal and mitochondrial MAVS have clear advantages for the host. Viruses are skilled pathogens, which can evade or subvert innate signaling pathways. Previous work has revealed that the NS3-4A serine protease from Hepatitis C virus cleaves MAVS from the mitochondrial membrane, thereby inactivating antiviral defenses. It will be important to determine whether NS3-4A also affects the peroxisomal MAVS pathway or whether this pathway is still functional. Undoubtedly, future studies will unveil additional immune evasion strategies employed by other viruses to subvert the early wave of interferon-stimulated gene expression induced by peroxisomal MAVS. In this context, it will be of great interest to further elaborate the molecular basis for peroxisomal MAVS signaling and delineate its role in the regulation of all MAVSdependent antiviral responses.
